Miconazole Nitrate, 15% Zinc Oxide, and 81.35% White Petrolatum Articles
Steifel acquires Barrier in $145M deal
30 June 2008
Barrier's 1st-qtr loss narrows 9%
12 May 2008
FDA approves Barrier's Xolegel
7 August 2006
Showing 1-3 of 3 articles
- 1
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
